RxDoctor Payments Data

Michael Medvecky, MD

Orthopaedic Surgery · New Haven, CTNPI 1649254079

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,200 of the $32,624 with a category attached, or 68.0%. Smith+Nephew accounts for 90.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $15,424 and has fallen 99.8% since, to $35 in 2025.

$32,624in general payments, 2019–2025

Across 54 payments — averaging $604.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$30K
  • Synthes GmbH$3K
  • Johnson & Johnson$140
  • Pacira Therapeutics, Inc.$125
  • Vericel Corporation$106
  • Polaris Technology Solutions LLC$35
  • plus $63 from 3 others

What the payments were for

  • Consulting fees$2,9909%
  • Speaking & faculty fees$22,20068%
  • Travel & lodging$5,57117%
  • Food & beverage$1,8636%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew40$29,631
Synthes GmbH5$2,523
Johnson & Johnson3$140
Pacira Therapeutics, Inc.1$125
Vericel Corporation1$106
Polaris Technology Solutions LLC1$35
Celularity Inc.1$31
Medartis Inc.1$17
Ferring Pharmaceuticals Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,624 in reported general payments places this provider in the 85th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$16,419
Medicare patients
51
Services billed
281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →